C

Cellectis

243 employees

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Gene editing
allogeneic
off-the-shef CART therapies
Oncology
Medical
Life sciences
Biopharma
genome engineering
T-Cell therapies

Date founded

1999

Funding rounds raised

Total raised

$43M

from 7 investors over 7 rounds

C

Cellectis raised $43M on December 28, 2022

Investors: European Investment Bank

C

Cellectis raised $6.8M on June 1, 2005

Investors: ODYSSEE VENTURE, Idinvest Partners and Andera Partners

C

Cellectis raised $7.2M on May 1, 2002

Investors: ODYSSEE VENTURE, Andera Partners and Idinvest Partners

FAQ